RIMKLA Antibody / NAAG synthetase A
Predicted to enable N-acetyl-L-aspartate-L-glutamate ligase activity. Predicted to be involved in glutamine family amino acid metabolic process. Predicted to be located in cytosol. Predicted to be active in cytoplasm.
Product Specifications
CAS Number
9007-83-4
Specifications
Western blot: 0.5-1 µg/mL, Direct ELISA: 0.1-0.5 µg/mL
UniProt
Q8IXN7
Host
Rabbit
Reactivity
Human
Immunogen
E. coli-derived recombinant human protein (amino acids Q19-K391) was used as the immunogen for the RIMKLA antibody.
Clonality
Polyclonal
Isotype
IgG
Applications
WB, Direct ELISA
Purity
Antigen affinity purified
Format
Antigen affinity purified
Buffer
Lyophilized from 1X PBS with 2% Trehalose
Reconstitution
Limitations
This RIMKLA antibody is available for research use only.
Storage Conditions
Formulation
0.5 mg/mL if reconstituted with 0.2ml sterile DI water
Applications Notes
Optimal dilution of the RIMKLA antibody should be determined by the researcher.
Image Legend
Western blot testing of human 1) SH-SY5Y and 2) 293T cell lysate with RIMKLA antibody. Predicted molecular weight ~43 kDa.
Documents
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD100 (Semaphorin-4D) (A8), CF640R conjugate, 0.1mg/mL
TNF alpha (J2D10), CF405S conjugate, 0.1mg/mL
CD45RO (190-2F2.5), CF740 conjugate, 0.1mg/mL
Mucin 5AC (MUC5AC) (58M1), CF568 conjugate, 0.1mg/mL
